Basic Information
Carisma Therapeutics is a biotechnology company developing CAR macrophages, a disruptive immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cell therapy for the treatment of human diseases.
Carisma Therapeutics, Inc.
Philadelphia,Pennsylvania,United States of America
15~50 people
January 01, 2016
admin@carmatherapeutics.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios